<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:59:34Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4705923" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4705923</identifier><datestamp>2016-01-11</datestamp><setSpec>jbc</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
      <journal-id journal-id-type="hwp">jbc</journal-id>
      <journal-id journal-id-type="pmc">jbc</journal-id>
      <journal-id journal-id-type="publisher-id">JBC</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Biological Chemistry</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0021-9258</issn>
      <issn pub-type="epub">1083-351X</issn>
      <publisher>
        <publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
        <publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4705923</article-id>
      <article-id pub-id-type="pmcid">PMC4705923</article-id>
      <article-id pub-id-type="pmc-uid">4705923</article-id>
      <article-id pub-id-type="pmid">26483544</article-id>
      <article-id pub-id-type="pmid">26483544</article-id>
      <article-id pub-id-type="publisher-id">M115.683268</article-id>
      <article-id pub-id-type="doi">10.1074/jbc.M115.683268</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Protein Structure and Folding</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structural Insights into the MMACHC-MMADHC Protein Complex Involved in Vitamin B<sub>12</sub> Trafficking<xref ref-type="fn" rid="FN1">*</xref></article-title>
        <alt-title alt-title-type="short">Characterization of the MMACHC-MMADHC Complex</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Froese</surname>
            <given-names>D. Sean</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
          <xref ref-type="author-notes" rid="FN2">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kopec</surname>
            <given-names>Jolanta</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>Â¶</sup>
          </xref>
          <xref ref-type="author-notes" rid="FN2">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fitzpatrick</surname>
            <given-names>Fiona</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>Â¶</sup>
          </xref>
          <xref ref-type="author-notes" rid="FN2">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schuller</surname>
            <given-names>Marion</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>Â¶</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McCorvie</surname>
            <given-names>Thomas J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>Â¶</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chalk</surname>
            <given-names>Rod</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>Â¶</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Plessl</surname>
            <given-names>Tanja</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fettelschoss</surname>
            <given-names>Victoria</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fowler</surname>
            <given-names>Brian</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baumgartner</surname>
            <given-names>Matthias R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>â¡</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>Â§</sup>
          </xref>
          <xref ref-type="aff" rid="aff4">
            <sup>â</sup>
          </xref>
          <xref ref-type="author-notes" rid="FN3">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yue</surname>
            <given-names>Wyatt W.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>Â¶</sup>
          </xref>
          <xref ref-type="author-notes" rid="FN3">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="cor2">
            <sup>4</sup>
          </xref>
        </contrib>
        <aff id="aff1">From the <label>â¡</label>Division of Metabolism and Children's Research Center, University Children's, Hospital, CH-8032 Zurich, Switzerland, </aff>
        <aff id="aff2"><label>Â§</label>radiz â Rare Disease Initiative Zurich, Clinical Research Priority Program for Rare Diseases, University of Zurich, CH-8032 Zurich, Switzerland, </aff>
        <aff id="aff3">the <label>Â¶</label>Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom, and </aff>
        <aff id="aff4">the <label>â</label>Zurich Center for Integrative Human Physiology, University of Zurich, 8057 Zurich, Switzerland</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>3</label> To whom correspondence may be addressed: <addr-line>Division of Metabolism and Children's Research Center, University Children's Hospital, Steinwiesstrasse 75, 8032 ZÃ¼rich, Switzerland.</addr-line> Tel.: <phone>41-44-266-77-22</phone>; Fax: <fax>41-44-266-71-76</fax>; E-mail: <email>matthias.baumgartner@kispi.uzh.ch</email>.</corresp>
        <corresp id="cor2"><label>4</label> To whom correspondence may be addressed: <addr-line>Structural Genomics Consortium, University of Oxford, Old Road Campus Research Bldg., Roosevelt Dr., Headington, Oxford OX3 7DQ, United Kingdom.</addr-line> Tel.: <phone>44-1865-617757</phone>; Fax: <fax>44-1865-617575</fax>; E-mail: <email>wyatt.yue@sgc.ox.ac.uk</email>.</corresp>
        <fn fn-type="equal" id="FN2">
          <label>1</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
        <fn fn-type="equal" id="FN3">
          <label>2</label>
          <p>Both authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>4</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>290</volume>
      <issue>49</issue>
      <fpage>29167</fpage>
      <lpage>29177</lpage>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>2</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
        <license license-type="open-access">
          <license-p><italic>Author's Choice</italic>âFinal version free via <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">Creative Commons CC-BY license</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="zbc04915029167.pdf"/>
      <abstract abstract-type="teaser">
        <p><bold>Background:</bold> Two intracellular proteins, MMACHC and MMADHC, functionally interact for cobalamin trafficking.</p>
        <p><bold>Results:</bold> MMADHC crystal structure reveals protein-interacting regions and unexpected homology to MMACHC; mutations on either protein interfere with complex formation via different mechanisms.</p>
        <p><bold>Conclusion:</bold> Complex formation likely depends on prior cobalamin processing and can be broken by disease mutations.</p>
        <p><bold>Significance:</bold> MMACHC-MMADHC heterodimerization forms the essential trafficking chaperone delivering cobalamin to client enzymes.</p>
      </abstract>
      <abstract>
        <p>Conversion of vitamin B<sub>12</sub> (cobalamin, Cbl) into the cofactor forms methyl-Cbl (MeCbl) and adenosyl-Cbl (AdoCbl) is required for the function of two crucial enzymes, mitochondrial methylmalonyl-CoA mutase and cytosolic methionine synthase, respectively. The intracellular proteins MMACHC and MMADHC play important roles in processing and targeting the Cbl cofactor to its destination enzymes, and recent evidence suggests that they may interact while performing these essential trafficking functions. To better understand the molecular basis of this interaction, we have mapped the crucial protein regions required, indicate that Cbl is likely processed by MMACHC prior to interaction with MMADHC, and identify patient mutations on both proteins that interfere with complex formation, via different mechanisms. We further report the crystal structure of the MMADHC C-terminal region at 2.2 â« resolution, revealing a modified nitroreductase fold with surprising homology to MMACHC despite their poor sequence conservation. Because MMADHC demonstrates no known enzymatic activity, we propose it as the first protein known to repurpose the nitroreductase fold solely for protein-protein interaction. Using small angle x-ray scattering, we reveal the MMACHC-MMADHC complex as a 1:1 heterodimer and provide a structural model of this interaction, where the interaction region overlaps with the MMACHC-Cbl binding site. Together, our findings provide novel structural evidence and mechanistic insight into an essential biological process, whereby an intracellular âtrafficking chaperoneâ highly specific for a trace element cofactor functions via protein-protein interaction, which is disrupted by inherited disease mutations.</p>
      </abstract>
      <kwd-group>
        <kwd>crystal structure</kwd>
        <kwd>metabolic disease</kwd>
        <kwd>protein-protein interaction</kwd>
        <kwd>site-directed mutagenesis</kwd>
        <kwd>small-angle x-ray scattering (SAXS)</kwd>
        <kwd>nitroreductase fold</kwd>
        <kwd>vitamin B12</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="award1">
          <funding-source>Wellcome Trust
<named-content content-type="funder-id">http://dx.doi.org/10.13039/100004440</named-content></funding-source>
          <award-id>092809/Z/10/Z</award-id>
        </award-group>
        <award-group id="award2">
          <funding-source>Schweizerische Nationalfonds zur FÃ¶rderung der Wissenschaftlichen Forschung
<named-content content-type="funder-id">http://dx.doi.org/10.13039/501100001711</named-content></funding-source>
          <award-id>31003A_156907</award-id>
          <award-id>31003A_138521</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Vitamin B<sub>12</sub> (referred hereafter as cobalamin, Cbl)<xref ref-type="fn" rid="FN4"><sup>5</sup></xref> is an essential cofactor for two human enzymes: cytosolic methionine synthase (MS, EC 2.1.1.13), which requires methyl-Cbl (MeCbl), and mitochondrial methylmalonyl-CoA mutase (MUT, EC 5.4.99.2), which requires adenosyl-Cbl (AdoCbl) (<xref rid="B1" ref-type="bibr">1</xref>). An intracellular pathway of at least seven human gene loci has evolved, encoding proteins responsible for the transport, processing and delivery of the appropriate Cbl form via a cytosol-targeted route to MS, and a mitochondrion-targeted route to MUT (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>). Mutations in any of the seven genes, depending on its relative position within the pathway, can result in three broad disease phenotypes collectively referred to as âintracellular Cbl disordersâ (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>). They include (i) homocystinuria (HC) associated with reduced MeCbl production and MS deficiency (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>), (ii) methylmalonic aciduria (MMA) associated with reduced AdoCbl production and MUT deficiency (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>), or (iii) a combined HC and MMA defect (HC+MMA) (<xref rid="B4" ref-type="bibr">4</xref>). MMACHC and MMADHC are two proteins involved in the early Cbl processing steps that are shared by both mitochondrial and cytosolic targeting routes. <italic>MMACHC</italic> gene mutations are the most common cause of Cbl metabolic disorders, resulting in HC+MMA (<xref rid="B8" ref-type="bibr">8</xref>). Genetic defects of <italic>MMADHC</italic>, by contrast, uniquely cause any of the above three phenotypes (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>).</p>
      <p>A possible explanation for the heterogeneous <italic>MMADHC</italic> phenotypes is the presence of distinct functional domains at the MMADHC protein level, responsible for trafficking to either mitochondrial MUT (of AdoCbl) or cytosolic MS (of MeCbl), or both. This hypothesis is supported by analysis of metabolic phenotypes from known disease mutations (<xref rid="B11" ref-type="bibr">11</xref>) and alanine-scanning mutagenesis (<xref rid="B12" ref-type="bibr">12</xref>). These studies dissect the 296-amino acid (aa) human MMADHC polypeptide functionally into the N-terminal 115 aa that is required for the mitochondrial route but dispensable for cytosolic trafficking, the C-terminal 180 aa that contribute to both routes, and two regions therein (aa 197â226 and 246â259) that have greater influence on the cytosolic than the mitochondrial route. Current knowledge points to a role of MMADHC in regulating Cbl delivery at the branch point between the mitochondrial and cytoplasmic target enzymes, albeit via an incompletely understood mechanism.</p>
      <p>Furthermore, despite the <italic>MMADHC</italic> gene discovery seven years ago (<xref rid="B10" ref-type="bibr">10</xref>), few of the biochemical properties and functions of the MMADHC protein are known. Although previously postulated to contain Cbl and ATP binding motifs (<xref rid="B10" ref-type="bibr">10</xref>), MMADHC has been shown not to bind Cbl (<xref rid="B13" ref-type="bibr">13</xref>) or to hydrolyze ATP (<xref rid="B14" ref-type="bibr">14</xref>). Further biochemical exploration has been hampered in part by a lack of structural knowledge or sequence homologues. The inability of MMADHC to bind Cbl has implicated protein-protein interaction as the means of its Cbl-targeting role. This is supported by recent evidence from phage display (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>), bacterial two-hybrid studies (<xref rid="B15" ref-type="bibr">15</xref>), native PAGE (<xref rid="B14" ref-type="bibr">14</xref>), and surface plasmon resonance (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>) that MMADHC interacts directly with MMACHC <italic>in vitro</italic> (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B15" ref-type="bibr">15</xref>), and the interaction does not require the N-terminal 115 aa of MMADHC (<xref rid="B14" ref-type="bibr">14</xref>). Because MMACHC has been shown structurally (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>) and biochemically (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>) to bind various Cbl forms, and to process the upper Cbl ligand by reductive decyanation (<xref rid="B19" ref-type="bibr">19</xref>) or dealkylation (<xref rid="B20" ref-type="bibr">20</xref>) using the flavin cofactors FMN/FAD and GSH, respectively, it seems plausible that MMACHC-bound Cbl can partner with MMADHC to be ferried to the two destination enzymes.</p>
      <p>To evaluate the importance and molecular basis of the MMACHC-MMADHC interaction, we have defined a minimal MMACHC interaction module of MMADHC, and demonstrated that experimental and patient missense mutations disrupt this interaction. We have further determined the structure of this interaction module from mouse MMADHC to 2.2 â« resolution, and established the 1:1 stoichiometry of the MMACHC-MMADHC heterodimer using small angle x-ray scattering (SAXS). Finally, based on the combined findings, we propose the first structural model of the MMACHC-MMADHC interaction.</p>
    </sec>
    <sec sec-type="methods">
      <title>Experimental Procedures</title>
      <sec>
        <title/>
        <sec>
          <title/>
          <sec>
            <title>Recombinant Production of MMACHC and MMADHC</title>
            <p>DNA fragments encoding human (<italic>Homo sapiens</italic>, IMAGE clone: 3826071) and mouse (<italic>Mus musculus</italic>, IMAGE clone: 3493526) MMADHC, harboring different N- and C-terminal boundaries, were amplified and subcloned into pNIC28-Bsa4 vector (GenBank<sup>TM</sup> accession number <ext-link ext-link-type="gen" xlink:href="EF198106">EF198106</ext-link>) in-frame with a tobacco etch virus protease cleavable N-terminal His<sub>6</sub> tag. Constructs of human <italic>Hs</italic>MMACHC in pNIC28-Bsa4 vector were prepared previously (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B21" ref-type="bibr">21</xref>). Site-directed mutations were constructed using the QuikChange mutagenesis kit (Stratagene) and confirmed by sequencing. Cloning and site-directed mutagenesis primers are available upon request. Proteins were expressed in <italic>Escherichia coli</italic> BL21(DE3)R3 and purified by affinity (Ni-Sepharose; GE Healthcare) and size-exclusion (Superdex 200; GE Healthcare) chromatography. For crystallization, MMADHC proteins were further purified by ion exchange chromatography (Resource Q; GE Healthcare). Selenomethionine (SeMet)-derivatized proteins were expressed using SelenoMethionine Medium Complete (Molecular Dimensions) and purified as above.</p>
          </sec>
          <sec>
            <title>Crystallization and Structural Determination</title>
            <p>Purified SeMet-derivatized and native <italic>Mm</italic>MMADHC<sub>Î128</sub> were concentrated to 15â20 mg/ml, and crystals were grown by sitting drop vapor diffusion at 4 Â°C. The mother liquor conditions are summarized in <xref ref-type="table" rid="T1">Table 1</xref>. Crystals were cryo-protected in mother liquor containing ethylene glycol (25% v/v) and flash-cooled in liquid nitrogen. X-ray diffraction data were collected at the Diamond Light Source beamline I04 and processed using XIA2. Selenium atoms were located using SHELXC/D (<xref rid="B22" ref-type="bibr">22</xref>) for initial phase calculation in SHELXE, and subsequently for automated building with BUCCANEER (<xref rid="B23" ref-type="bibr">23</xref>). The structure was solved by selenium single-wavelength anomalous diffraction phasing and refined using PHENIX (<xref rid="B24" ref-type="bibr">24</xref>), followed by manual rebuilding in COOT (<xref rid="B25" ref-type="bibr">25</xref>). The SeMet MMADHC model was used to solve the native structure by molecular replacement using PHASER (<xref rid="B26" ref-type="bibr">26</xref>). The final refined model consists of aa 132â157, 169â236, and 246â296 of <italic>Mm</italic>MMADHC. Atomic coordinates and structure factors for <italic>Mm</italic>MMADHC<sub>Î128</sub> have been deposited in the Protein Data Bank with the accession code <ext-link ext-link-type="pdb" xlink:href="5A4R">5A4R</ext-link>. Data collection and refinement statistics are summarized in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
          </sec>
          <sec>
            <title>Small Angle X-ray Scattering</title>
            <p>For SAXS, MMACHC and MMADHC were cleaved by tobacco etch virus protease to remove the N-terminal His<sub>6</sub> tag, followed by reverse affinity purification. Purified proteins were then incubated separately or together with the appropriate ligands and further purified by size-exclusion chromatography. Concentrations of proteins used were 24 mg/ml (MMADHC), 18 mg/ml (MMACHC), and 17 mg/ml (complex). Scattering data were collected at the Diamond Light Source B21 beamline. Data collection was performed either in-line with size-exclusion chromatography (KW404 column, Shodex) or in batch mode where the peak fractions were collected and immediately subjected to SAXS by flowing sample through an in-vacuum quartz capillary of 1.6-mm diameter. Data were collected using a Pilatus 2M detector (DECTRIS, Baden, Switzerland) at a sample-detector distance of 3914 mm and a wavelength of Î» = 1 â«. The range of momentum transfer of 0.1 &lt; <italic>s</italic> &lt; 5 nm<sup>â1</sup> was covered (<italic>s</italic> = 4ÏsinÎ¸/Î», where Î¸ is the scattering angle). For the in-line mode, 1-s exposures were collected, whereas for batch samples, a comparison of eighteen 10-s exposures was performed. Radiation damage was checked for the batch mode by monitoring changes in radius of gyration in each frame, where no significant changes were observed. The data were radially averaged, and the scattering of the buffer was subtracted. The forward scattering <italic>I</italic>(0), radius of gyration <italic>R<sub>g</sub></italic>, pair distribution of the particle P(r), and maximum dimension <italic>D</italic><sub>max</sub> were analyzed using Scatter (<xref rid="B27" ref-type="bibr">27</xref>) and the ATSAS suite of programs (<xref rid="B28" ref-type="bibr">28</xref>).</p>
          </sec>
          <sec>
            <title>Solution Characterization of MMACHC and MMADHC</title>
            <p>Blue native-PAGE was performed with 25 Î¼<sc>m</sc> protein (MMACHC and/or MMADHC) alone or in the presence of 50 Î¼<sc>m</sc> cobalamin (MeCbl, AdoCbl, CNCbl) and/or 8 m<sc>m</sc> ligand (GSH, FMN, FAD), which was loaded onto the native-PAGE gel system, after preincubation in the dark at room temperature for 1 h, and then run following the manufacturer's instructions (Life Technologies). All blue native-PAGE experiments were performed at least twice independently. Analytical gel filtration (<xref rid="B16" ref-type="bibr">16</xref>), FMN/FAD binding by intrinsic fluorescence quenching (<xref rid="B17" ref-type="bibr">17</xref>), and differential scanning fluorimetry (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B29" ref-type="bibr">29</xref>), were performed as described previously. For native mass spectrometry, 75 Î¼l of sample containing â¼4 mg/ml MMADHC and MMACHC incubated in the presence of 0.5 m<sc>m</sc> MeCbl and 2 m<sc>m</sc> reduced GSH underwent four desalting steps using Micro Bio-Spin columns (Bio-Rad) that were pre-equilibrated with 50 m<sc>m</sc> ammonium acetate buffer (pH 6.5). Following desalting, samples were loaded into a 1.0-ml gas-tight positive displacement syringe (Hamilton) that was inserted into the syringe pump. Samples were then directly infused with a constant flow rate of 6 Î¼l/min through a PEEK capillary tubing (inner diameter, 0.005 inches) into a Q-TOF 6530 mass spectrometer attached to a standard electrospray ionization source (Agilent Technologies). The mass spectrometer was operated in positive ion mode, using the 1-GHz detector mode with a scan range of 100â20,000 <italic>m/z</italic> and a fragmentor voltage of 430 V. Following data acquisition, results were evaluated by using the MassHunter Qualitative Analysis software (Agilent Technologies).</p>
          </sec>
        </sec>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title/>
        <sec>
          <title/>
          <sec>
            <title>MMADHC aa 154â296 Is an MMACHC Interaction Module</title>
            <p>To better understand the required regions, ligand dependence, and stoichiometry of their <italic>in vitro</italic> interactions, we generated a series of human (<italic>Hs</italic>) MMADHC and MMACHC truncation proteins by recombinant expression (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>A</italic>). Using blue native-PAGE (BN-PAGE) (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>), full-length MMACHC (<italic>Hs</italic>MMACHC<sub>FL</sub>) alone migrated as two bands (<italic>lane 1</italic>), consistent with its known monomeric and dimeric forms, whereas the dimeric band became more prominent in the presence of MeCbl and GSH (<italic>lane 2</italic>, <italic>white dot</italic>). The <italic>Hs</italic>MMADHC proteins with various N-terminal truncations migrated as single bands (<italic>lanes 3â8</italic>) corresponding to their respective monomers, corroborating previous investigations (<xref rid="B13" ref-type="bibr">13</xref>). Complex formation, as judged by the appearance of an additional band in BN-PAGE as compared with single-protein controls, was observed when <italic>Hs</italic>MMACHC<sub>FL</sub> preincubated with MeCbl and GSH was added to <italic>Hs</italic>MMADHC<sub>Î61</sub> or <italic>Hs</italic>MMADHC<sub>Î123</sub>, or to a lesser extent, <italic>Hs</italic>MMADHC<sub>Î153</sub> (<italic>lanes 9â11</italic>, <italic>white asterisk</italic>). However,no complex band was observed with N-terminal truncation of <italic>Hs</italic>MMADHC beyond aa 154 (<italic>Hs</italic>MMADHC<sub>Î157</sub>, <italic>Hs</italic>MMADHC<sub>Î167</sub>, or <italic>Hs</italic>MMADHC<sub>Î172</sub>; <italic>lanes 12â14</italic>) under the same conditions. The <italic>Hs</italic>MMADHC-<italic>Hs</italic>MMACHC complex bands migrated at a position intermediate of the estimated monomeric and dimeric <italic>Hs</italic>MMACHC bands, suggesting a possible 1:1 heterodimeric complex. <italic>Hs</italic>MMACHC<sub>ÎC</sub>, which lacks the C-terminal Pro-rich region (aa 236â282; <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>A</italic>), was sufficient for complex formation with <italic>Hs</italic>MMADHC<sub>Î123</sub> (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>, <italic>lane 2</italic>). Size-exclusion chromatography using <italic>Mm</italic>MMADHC<sub>Î128</sub> and <italic>Hs</italic>MMACHC<sub>ÎC</sub> proteins further confirmed the regions required for interaction and the 1:1 stoichiometry of the complex (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>D</italic>). Therefore, the MMADHC region C-terminal to aa 154 and the MMACHC region without the Pro-rich C terminus is sufficient for direct protein-protein interaction. Notably, the MMADHC C-terminal region is the most evolutionarily conserved section of the polypeptide from human to <italic>Caenorhabditis elegans</italic> (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>E</italic>), suggesting selected retention of this interaction module in evolution.</p>
            <fig id="F1" orientation="portrait" position="float">
              <label>FIGURE 1.</label>
              <caption>
                <p><bold>Interaction study of MMACHC and MMADHC.</bold>
<italic>A</italic>, domain diagram showing recombinant human MMACHC and MMADHC constructs described in this figure. For reference, mouse construct <italic>Mm</italic>MMADHC<sub>Î128</sub> used to generate the crystal structure is also shown. <italic>B</italic>, interaction of human MMACHC full-length and MMADHC truncated proteins by BN-PAGE. <italic>Lanes 1â8</italic>: <italic>single protein</italic> controls including MMACHC<sub>FL</sub> alone (<italic>lane 1</italic>) and with MeCbl and GSH (<italic>lane 2</italic>); and MMADHC truncations including MMADHC<sub>Î61</sub> (<italic>lane 3</italic>), MMADHC<sub>Î123</sub> (<italic>lane 4</italic>), MMADHC<sub>Î153</sub> (<italic>lane 5</italic>), MMADHC<sub>Î157</sub> (<italic>lane 6</italic>), MMADHC<sub>Î167</sub> (<italic>lane 7</italic>), and MMADHC<sub>Î172</sub> (<italic>lane 8</italic>). <italic>Lanes 9â14</italic>: <italic>combined protein</italic> incubation of MMACHC<sub>FL</sub> in presence of MeCbl and GSH with MMADHC<sub>Î61</sub> (<italic>lane 9</italic>), MMADHC<sub>Î123</sub> (<italic>lane 10</italic>), MMADHC<sub>Î153</sub> (<italic>lane 11</italic>), MMADHC<sub>Î157</sub> (<italic>lane 12</italic>), MMADHC<sub>Î167</sub> (<italic>lane 13</italic>), and MMADHC<sub>Î172</sub> (<italic>lane 14</italic>). <italic>C</italic>, interaction of MMACHC mutants and MMADHC<sub>Î123</sub> by BN-PAGE, in the presence of MeCbl and GSH. <italic>Lanes 1â6</italic>: MMACHC<sub>ÎC</sub> alone (<italic>lane 1</italic>) and with MMADHC<sub>Î123</sub> (<italic>lane 2</italic>); MMACHC<sub>R161Q</sub> alone (<italic>lane 3</italic>) and with MMADHC<sub>Î123</sub> (<italic>lane 4</italic>); and MMACHC<sub>ÎPNR</sub> alone (<italic>lane 5</italic>) and with MMADHC<sub>Î123</sub> (<italic>lane 6</italic>). For <italic>B</italic> and <italic>C</italic>, <italic>white dots</italic> indicate MMACHC homodimer, and <italic>white asterisks</italic> indicate MMACHC-MMADHC heterodimer. <italic>D</italic>, analysis of complex formation by size-exclusion chromatography including chromatographs of <italic>Mm</italic>MMADHC<sub>Î123</sub> (<italic>gray line</italic>), <italic>Hs</italic>MMACHC<sub>ÎC</sub> + MeCbl + GSH (<italic>black line</italic>), and <italic>Mm</italic>MMADHC<sub>Î123</sub> + <italic>Hs</italic>MMACHC<sub>ÎC</sub> + MeCbl + GSH (<italic>black dotted line</italic>). <italic>x</italic> axis: elution volume; <italic>left y</italic> axis: absorbance (milliabsorbance units (<italic>mAU</italic>)) for <italic>Hs</italic>MMACHC<sub>ÎC</sub> + MeCbl + GSH; right <italic>y</italic> axis: absorbance (mAU) for <italic>Mm</italic>MMADHC<sub>Î123</sub> and <italic>Mm</italic>MMADHC<sub>Î123</sub> + <italic>Hs</italic>MMACHC<sub>ÎC</sub> + MeCbl + GSH. Molecular weights of each peak are calculated from a calibration curve using molecular weight protein standards (Sigma-Aldrich). <italic>E</italic>, sequence alignment of MMADHC from <italic>H. sapiens</italic> (<italic>HS</italic>, NP_056517.1, human) and predicted MMADHC protein (Y76A2B.5) from <italic>C. elegans</italic> (<italic>Ce</italic>) using the BLAST server (<ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>). The <italic>boxed region</italic> represents the smallest interacting construct of <italic>Hs</italic>MMADHC for <italic>Hs</italic>MMACHC. <italic>F</italic>, BN-PAGE of <italic>Hs</italic>MMACHC<sub>FL</sub> and <italic>Hs</italic>MMADHC<sub>Î123</sub> under various conditions. <italic>White asterisks</italic> indicate MMACHC-MMADHC heterodimer. <italic>G</italic>, native mass spectrometry of <italic>Hs</italic>MMACHC<sub>FL</sub> and <italic>Hs</italic>MMADHC<sub>Î123</sub> incubated with MeCbl and GSH. Expected sizes: <italic>Hs</italic>MMACHC<sub>FL</sub>, 31818.6 Da; <italic>Hs</italic>MMADHC<sub>Î123</sub>, 19727.7 Da; MeCbl, 1343.6 Da; and GSH, 307.3 Da.</p>
              </caption>
              <graphic xlink:href="zbc0521532450001"/>
            </fig>
            <p>In agreement with previous work (<xref rid="B14" ref-type="bibr">14</xref>), complex formation is favored by preincubation of proteins with GSH and MeCbl, conditions known to facilitate upper Cbl ligand (R-group) removal. We observed either significantly weaker or no interaction between <italic>Hs</italic>MMACHC<sub>FL</sub> and <italic>Hs</italic>MMADHC<sub>Î123</sub> when GSH was replaced by other reducing factors (FMN, FAD, DTT) or when MeCbl was replaced by other Cbl forms (AdoCbl, CNCbl) (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>F</italic>), conditions known to result in much slower (&gt;10-fold) or no R-group removal (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). We further investigated two <italic>Hs</italic>MMACHC mutants with reduced MeCbl dealkylation activity (<italic>Hs</italic>MMACHC<sub>ÎPNR</sub>, missing aa 109â111 (<xref rid="B16" ref-type="bibr">16</xref>), or <italic>Hs</italic>MMACHC<sub>R161Q</sub> (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B32" ref-type="bibr">32</xref>)), on their ability to complex with <italic>Hs</italic>MMADHC<sub>Î123</sub>. Upon incubation with MeCbl and GSH, the <italic>Hs</italic>MMACHC<sub>R161Q</sub> mutant was less able than <italic>Hs</italic>MMACHC<sub>FL</sub> to complex with <italic>Hs</italic>MMADHC<sub>Î123</sub> (compare <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>, <italic>lane 4</italic> with <xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>, <italic>lane 10</italic>), whereas <italic>Hs</italic>MMACHC<sub>ÎPNR</sub> did not complex with <italic>Hs</italic>MMADHC<sub>Î123</sub> at all (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>C</italic>, <italic>lane 6</italic>).</p>
            <p>The MMACHC-MMADHC interaction is further studied by native mass spectrometry, where the complex of <italic>Hs</italic>MMACHC<sub>FL</sub> and <italic>Hs</italic>MMADHC<sub>Î123</sub>, incubated in the presence of MeCbl and GSH, generated two peaks consistent with a 1:1 stoichiometry, one missing the 15 atomic mass units of the methyl group (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>G</italic>, 52,875 atomic mass units) and the other missing 16 atomic mass units, corresponding to the methyl group plus the hydrogen from GSH (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>G</italic>, 53,181 atomic mass units). Thus, R-group removal appears to be a prerequisite for MMACHC-MMADHC interaction.</p>
          </sec>
          <sec>
            <title>MMADHC Contains a Nitroreductase-like Fold with Homology to MMACHC</title>
            <p>We next characterized MMADHC by x-ray crystallography to elucidate the molecular properties of its MMACHC interaction module. To maximize the probability of crystallization, we adopted a cross-species approach that involved the study of recombinant human, <italic>M. musculus</italic>, and <italic>Xenopus laevis</italic> MMADHC proteins, coupled with an extensive survey of construct boundaries. From &gt;40 purified proteins, we successfully crystallized <italic>M. musculus</italic> MMADHC aa 129â296 (<italic>Mm</italic>MMADHC<sub>Î128</sub>; <xref ref-type="fig" rid="F1">Figs. 1</xref><italic>A</italic> and <xref ref-type="fig" rid="F2">2</xref>A), a region bearing 93% identity with the human sequence. In our BN-PAGE assay, <italic>Mm</italic>MMADHC(<italic>e.g. Mm</italic>MMADHC<sub>Î128</sub>) can substitute the equivalent human construct in stable complex formation with <italic>Hs</italic>MMACHC (not shown). Despite repeated attempts, the equivalent <italic>Hs</italic>MMADHC construct did not crystallize. The structure of <italic>Mm</italic>MMADHC<sub>Î128</sub> (<xref ref-type="fig" rid="F2">Fig. 2</xref>, <italic>A</italic> and <italic>B</italic>), determined to 2.6 â« resolution by single-wavelength anomalous dispersion phasing for the selenomethionine (SeMet) derivative, and to 2.2 â« by molecular replacement for the native protein (<xref ref-type="table" rid="T1">Table 1</xref>), is a mixed Î±/Î² domain composed of a central four-stranded antiparallel Î²-sheet (Î²1, Î²2, Î²6, Î²3) flanked by a 14-turn helix (Î±B) and a short Î²-turn (Î²4-Î²5) (<xref ref-type="fig" rid="F2">Fig. 2</xref><italic>C</italic>).</p>
            <fig id="F2" orientation="portrait" position="float">
              <label>FIGURE 2.</label>
              <caption>
                <p><bold>Structure of the MMACHC interaction module of MMADHC.</bold>
<italic>A</italic>, graphic representation of the <italic>Mm</italic>MMADHC<sub>Î128</sub> structure in orthogonal views. Secondary structures are colored <italic>green</italic> for Î²-sheets and <italic>red</italic> for Î±-helices. The first (aa 132) and last (aa 296) residues observed in the structure are labeled with <italic>N</italic> and <italic>C</italic>, respectively. <italic>Dotted lines</italic> indicate disordered regions. <italic>Inset</italic>: view of the Ï-weighted (2<italic>F<sub>o</sub></italic> â <italic>F<sub>c</sub></italic>) electron density map of <italic>Mm</italic>MMADHC<sub>Î128</sub> aa region 190â217, contoured at Ï = 1. <italic>B</italic>, surface representation of <italic>Mm</italic>MMADHC<sub>Î128</sub> (same orientation as <italic>A</italic>, <italic>right panel</italic>) highlighting the three protrusions (Pr1âPr3) in <italic>blue. C</italic>, topology diagram of the <italic>Mm</italic>MMADHC<sub>Î128</sub> secondary structure with the same coloring and labeling as in <italic>A</italic> and <italic>B</italic>. Disordered regions are shown as <italic>dashed lines</italic>.</p>
              </caption>
              <graphic xlink:href="zbc0521532450002"/>
            </fig>
            <table-wrap id="T1" orientation="portrait" position="float">
              <label>TABLE 1</label>
              <caption>
                <p>
                  <bold>Data collection and refinement statistics for <italic>Mm</italic>MMADHC structure</bold>
                </p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead valign="bottom">
                  <tr>
                    <th rowspan="1" colspan="1"/>
                    <th align="center" rowspan="1" colspan="1"><italic>Mm</italic>MMADHC<sub>Î128</sub> SeMet<xref ref-type="table-fn" rid="TF1-1"><italic><sup>a</sup></italic></xref></th>
                    <th align="center" rowspan="1" colspan="1"><italic>Mm</italic>MMADHC<sub>Î128</sub> native<xref ref-type="table-fn" rid="TF1-2"><italic><sup>b</sup></italic></xref></th>
                  </tr>
                </thead>
                <tbody valign="top">
                  <tr>
                    <td align="left" rowspan="1" colspan="1">
                      <bold>Data collection and processing</bold>
                      <xref ref-type="table-fn" rid="TF1-3">
                        <italic>
                          <sup>c</sup>
                        </italic>
                      </xref>
                    </td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââBeamline</td>
                    <td align="left" rowspan="1" colspan="1">Diamond I04</td>
                    <td align="left" rowspan="1" colspan="1">Diamond I04</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââWavelength (Ã)</td>
                    <td align="left" rowspan="1" colspan="1">0.9782</td>
                    <td align="left" rowspan="1" colspan="1">0.9782</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââUnit cell parameters a, b, c (Ã)</td>
                    <td align="left" rowspan="1" colspan="1">73.5 88.7 65.7</td>
                    <td align="left" rowspan="1" colspan="1">74.2 89.5 64.7</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââUnit cell parameters Î±, Î², Î³ (Â°)</td>
                    <td align="left" rowspan="1" colspan="1">90.00 90.00 90.00</td>
                    <td align="left" rowspan="1" colspan="1">90.00 90.00 90.00</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââSpace group</td>
                    <td align="left" rowspan="1" colspan="1">C 2 2 21</td>
                    <td align="left" rowspan="1" colspan="1">C 2 2 21</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââResolution range (Ã)</td>
                    <td align="left" rowspan="1" colspan="1">44.33â2.61 (2.68â2.61)</td>
                    <td align="left" rowspan="1" colspan="1">44.76â2.25 (2.31â2.25)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââObserved/Unique reflections</td>
                    <td align="left" rowspan="1" colspan="1">78,726/6293 (6117/471)</td>
                    <td align="left" rowspan="1" colspan="1">51,530/10,530 (3778/762)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>sym</sub> (%)</td>
                    <td align="left" rowspan="1" colspan="1">12.2 (54.8)</td>
                    <td align="left" rowspan="1" colspan="1">2.5 (59.8)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââCC1/2</td>
                    <td align="left" rowspan="1" colspan="1">0.99 (0.96)</td>
                    <td align="left" rowspan="1" colspan="1">1.0 (0.80)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââ<italic>I</italic>/Ï(<italic>I</italic>)</td>
                    <td align="left" rowspan="1" colspan="1">15.1 (4.7)</td>
                    <td align="left" rowspan="1" colspan="1">31.6 (2.6)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââCompleteness (%)</td>
                    <td align="left" rowspan="1" colspan="1">Anomalous 92.1 (98.8)</td>
                    <td align="left" rowspan="1" colspan="1">99.8 (99.6)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââMultiplicity</td>
                    <td align="left" rowspan="1" colspan="1">Anomalous 6.7 (6.8)</td>
                    <td align="left" rowspan="1" colspan="1">4.9 (5.0)</td>
                  </tr>
                  <tr>
                    <td colspan="3" rowspan="1">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="3">
                      <bold>Refinement</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>cryst</sub> (%)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">22.9</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââ<italic>R</italic><sub>free</sub> (%)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">25.5</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââWilson <italic>B</italic> factor (Ã<sup>2</sup>)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">55.5</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââAverage total <italic>B</italic> factor (Ã<sup>2</sup>)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">66.2</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââr.m.s.d. bond length (Ã<sup>2</sup>)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">0.0034</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââr.m.s.d. bond angle (Â°)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">0.87</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââMissing residues</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">129â131, 160â168, 237â245</td>
                  </tr>
                  <tr>
                    <td colspan="3" rowspan="1">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="3">
                      <bold>MolProbity analysis</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââClashscore</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">5.98 (98th percentile)</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââRamachandran favored (%)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">96.48%</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââRamachandran disallowed (%)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">0.00%</td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">ââââRotamer outliers (%)</td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">0.00%</td>
                  </tr>
                  <tr>
                    <td colspan="3" rowspan="1">
                      <hr/>
                    </td>
                  </tr>
                  <tr>
                    <td align="left" rowspan="1" colspan="1">
                      <bold>PDB code</bold>
                    </td>
                    <td rowspan="1" colspan="1"/>
                    <td align="left" rowspan="1" colspan="1">
                      <ext-link ext-link-type="pdb" xlink:href="5A4R">5A4R</ext-link>
                    </td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="TF1-1">
                  <p><italic><sup>a</sup></italic> Crystallization condition: 28% PEG3350, 100 m<sc>m</sc> Bis-Tris, pH 6.5, 250 m<sc>m</sc> NaCl.</p>
                </fn>
                <fn id="TF1-2">
                  <p><italic><sup>b</sup></italic> Crystallization condition: 22% polyacrylic acid 5100, 100 m<sc>m</sc> HEPES, pH 7.5, 20 m<sc>m</sc> MgCl<sub>2</sub>.</p>
                </fn>
                <fn id="TF1-3">
                  <p><italic><sup>c</sup></italic> Data from highest resolution shell are shown in parentheses.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p>A structural comparison of <italic>Mm</italic>MMADHC<sub>Î128</sub> with other proteins using DALI (<xref rid="B33" ref-type="bibr">33</xref>) revealed that the core structure is derived from the nitroreductase (NTR) fold (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>A</italic>), primarily found in flavoenzymes and oxidoreductases that utilize FMN/FAD cofactors and form homodimers by Î²-strand exchange, as well as MMACHC (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>B</italic>). Nevertheless, <italic>Mm</italic>MMADHC<sub>Î128</sub> has extensively modified the NTR fold with three loop protrusions (Pr1âPr3), rendering it functionally different from classical NTRs. Firstly, <italic>Mm</italic>MMADHC<sub>Î128</sub> does not bind FMN/FAD in solution (data not shown) because the canonical binding site found in NTRs is disrupted by part of the MMADHC Pr2 loop protrusion (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>A</italic>). Secondly, although <italic>in crystallo Mm</italic>MMADHC<sub>Î128</sub> reveals a symmetry-related dimer, its dimeric interface does not match that of the conventional NTRs (<xref ref-type="fig" rid="F4">Fig. 4</xref><italic>B</italic>). Indeed, <italic>Mm</italic>MMADHC<sub>Î128</sub> is a monomer in solution by BN-PAGE, size-exclusion chromatography (not shown), and SAXS (see âA Structural Model of the MMACHC-MMADHC Complexâ), consistent with <italic>Hs</italic>MMADHC constructs migrating as monomers in BN-PAGE (<xref ref-type="fig" rid="F1">Fig. 1</xref><italic>B</italic>).</p>
            <fig id="F3" orientation="portrait" position="float">
              <label>FIGURE 3.</label>
              <caption>
                <p><bold>Structural comparison of MMADHC and proteins of the nitroreductase family.</bold>
<italic>A</italic>, structural superposition of <italic>Mm</italic>MMADHC<sub>Î128</sub> (<italic>red</italic>) and two other NTRs (Protein Data Bank (PDB): <ext-link ext-link-type="pdb" xlink:href="2HAY">2HAY</ext-link>, <ext-link ext-link-type="pdb" xlink:href="2ISL">2ISL</ext-link>; <italic>gray</italic>). <italic>B</italic>, superposition of <italic>Mm</italic>MMADHC<sub>Î128</sub> (<italic>red</italic>) and MMACHC (PDB: <ext-link ext-link-type="pdb" xlink:href="3SOM">3SOM</ext-link>; <italic>gray</italic>), highlighting the absence of the <italic>Hs</italic>MMACHC four-helix cap domain (aa 185â234) in <italic>Mm</italic>MMADHC<sub>Î128</sub> as well as the different orientations of protrusions Pr1 and Pr2 (<italic>Hs</italic>MMACHC: Pr1 aa 69â77; Pr2 aa 104â116; <italic>Mm</italic>MMADHC<sub>Î128</sub>: Pr1 aa 183â190, Pr2 aa 227â246) between the proteins. Protrusions (Pr1âPr3) are colored <italic>blue</italic> for <italic>Mm</italic>MMADHC<sub>Î128</sub> and <italic>yellow</italic> for <italic>Hs</italic>MMACHC.</p>
              </caption>
              <graphic xlink:href="zbc0521532450003"/>
            </fig>
            <fig id="F4" orientation="portrait" position="float">
              <label>FIGURE 4.</label>
              <caption>
                <p><bold>Comparison of MMADHC to other NTR dimers.</bold>
<italic>A</italic>, overlay of the <italic>Mm</italic>MMADHC<sub>Î128</sub> structure (<italic>red</italic>) with nitroreductases from <italic>Desulfovibrio desulfuricans</italic> (PDB: <ext-link ext-link-type="pdb" xlink:href="3E39">3E39</ext-link>), <italic>Streptococcus pyogenes</italic> (PDB: <ext-link ext-link-type="pdb" xlink:href="2HAY">2HAY</ext-link>), and <italic>Enterobacter cloacae</italic> (PDB: <ext-link ext-link-type="pdb" xlink:href="1KQD">1KQD</ext-link>). The canonical FMN/FAD binding site of NTRs (<italic>left</italic>, indicated by the <italic>green stick ligand</italic>), located at the conventional dimer interface, is not present in MMADHC (<italic>right</italic>) due to disruption by its protrusion loop Pr2. <italic>B</italic>, structural alignment of a single subunit (protomer A) of <italic>Mm</italic>MMADHC<sub>Î128</sub> (MMADHC), <italic>Hs</italic>MMACHC<sub>FL</sub> (MMACHC, PDB: <ext-link ext-link-type="pdb" xlink:href="3SOM">3SOM</ext-link>), and an NTR (PDB: <ext-link ext-link-type="pdb" xlink:href="1KQD">1KQD</ext-link>) in <italic>gray</italic>, with the second subunit (protomer B) of their crystallographic dimers color-coded (MMADHC in <italic>blue</italic>; NTR in <italic>yellow</italic>; MMACHC in <italic>red</italic>), demonstrating the lack of a conserved dimeric orientation and interface among the three structures.</p>
              </caption>
              <graphic xlink:href="zbc0521532450004"/>
            </fig>
            <p>To our surprise, the closest structural homologue of MMADHC is its interaction partner MMACHC (DALI (<xref rid="B33" ref-type="bibr">33</xref>) Z-score, 5.2), despite a lack of obvious sequence conservation. Like MMADHC, MMACHC contains three loop protrusions, at equivalent spatial positions, in the core NTR fold (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>) (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>B</italic>). MMACHC also lacks the classical FMN binding site present among NTRs, while retaining the ability to bind flavins in solution (<xref rid="B17" ref-type="bibr">17</xref>), likely involving a non-canonical binding site (<xref rid="B16" ref-type="bibr">16</xref>). The MMADHC and MMACHC structures superimpose only moderately and within the core NTR secondary structure elements (C<sup>Î±</sup>-r.m.s.d. 3.0 â«, 96 aligned aa), beyond which they differ substantially (<xref ref-type="fig" rid="F3">Fig. 3</xref><italic>B</italic>). For example, <italic>Mm</italic>MMADHC<sub>Î128</sub> does not contain the four-helix cap domain and differs in length and conformation of two protrusions as compared with MMACHC, all of which form part of the MMACHC Cbl binding pocket (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). These extensive structural differences from MMACHC likely account for the reported lack of Cbl binding capability of MMADHC (<xref rid="B13" ref-type="bibr">13</xref>). We additionally found no sequence elements or homology consistent with ATPase activity.</p>
          </sec>
          <sec>
            <title>Patient and Experimental MMADHC Mutations Knock Out Interaction with MMACHC</title>
            <p>Our previous mutagenesis studies in patient fibroblasts (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>) revealed specific MMADHC regions responsible for the intracellular targeting of the two cobalamin cofactors. These mutations correlate with the MMA, HC, or HC+MMA phenotypes based on their amino acid location (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>A</italic>). Missense mutations causing decreased MeCbl production (HC phenotype) or both AdoCbl and MeCbl production (HC+MMA phenotype) in cells are found within three sequence stretches at the MMADHC C-terminal half (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>A</italic>, <italic>stretches 1â3</italic>). When mapped onto our <italic>Mm</italic>MMADHC<sub>Î128</sub> structure, these three stretches cluster in spatial proximity and are surface-accessible (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>B</italic>). We investigated whether these mutations impact on the MMACHC-MMADHC interaction by introducing onto the <italic>Hs</italic>MMADHC<sub>Î123</sub> construct a selection of HC and HC+MMA causing mutations from the three stretches (Stretch 1: p.T182N, p.M186A, p.W189A; Stretch 2: p.D226A; Stretch 3: p.L259P). The recombinant mutant proteins behaved similarly to wild type in terms of expression level, protein solubility (not shown), and thermal stability (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>C</italic>), where only p.D226A led to slightly unstable protein. We found interaction of <italic>Hs</italic>MMACHC<sub>FL</sub> (incubated with MeCbl and GSH) with <italic>Hs</italic>MMADHC<sub>Î123-T182N</sub> and <italic>Hs</italic>MMADHC<sub>Î123-W189A</sub> to be severely decreased (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>D</italic>, <italic>lanes 3</italic> and <italic>5</italic>), but retainedfor <italic>Hs</italic>MMADHC<sub>Î123-M186A</sub>, <italic>Hs</italic>MMADHC<sub>Î123-D226A</sub>, and <italic>Hs</italic>MMADHC<sub>Î123-L259P</sub> (<xref ref-type="fig" rid="F5">Fig. 5</xref><italic>D</italic>, <italic>lanes 4</italic>, <italic>6</italic>, and <italic>7</italic>). These findings suggest that residues within Stretch 1 (Thr-182, Trp-189) occur at the binding interface with MMACHC.</p>
            <fig id="F5" orientation="portrait" position="float">
              <label>FIGURE 5.</label>
              <caption>
                <p><bold>Structural and biochemical analysis of MMADHC missense mutations.</bold>
<italic>A</italic>, domain diagram of MMADHC, with missense mutations color-coded according to their cellular defects (<xref rid="B10" ref-type="bibr">10</xref><xref ref-type="bibr" rid="B11">â</xref><xref rid="B12" ref-type="bibr">12</xref>), namely MMA (<italic>green</italic>), combined HC+MMA (stretch 1, <italic>red</italic>), or HC (stretches 2 and 3, <italic>blue</italic>) phenotypes. <italic>Purple line</italic> indicates aa region observed in the crystal structure. <italic>B</italic>, graphic (<italic>left</italic>) and surface (<italic>right</italic>) representations of <italic>Mm</italic>MMADHC<sub>Î128</sub> mapped with stretches 1â3 and individual mutations found within these regions. <italic>Dotted lines</italic> indicate disordered regions. <italic>C</italic>, analysis of thermal unfolding curves of various protein constructs reveals a melting temperature (<italic>T<sub>m</sub></italic>) of 62 Â°C (<italic>right</italic>) for <italic>Hs</italic>MMADHC<sub>Î123</sub>, which is relatively unchanged for all mutants with the exception of <italic>Hs</italic>MMADHC<sub>Î123-D226A</sub> where the <italic>T<sub>m</sub></italic> is slightly decreased as compared with wild type. <italic>Error bars</italic> indicate means Â± S.E. <italic>D</italic>, interaction of <italic>Hs</italic>MMACHC<sub>FL</sub> with wild-type or mutant <italic>Hs</italic>MMADHC<sub>Î123</sub> studied by BN-PAGE. Depicted are: <italic>Hs</italic>MMACHC<sub>FL</sub> with MeCbl and GSH alone (<italic>lane 1</italic>), and in combination with <italic>Hs</italic>MMADHC<sub>Î123</sub> (<italic>lane 2</italic>), <italic>Hs</italic>MMADHC<sub>Î123-T182N</sub> (<italic>lane 3</italic>), <italic>Hs</italic>MMADHC<sub>Î123-M186A</sub> (<italic>lane 4</italic>), <italic>Hs</italic>MMADHC<sub>Î123-W189A</sub> (<italic>lane 5</italic>), <italic>Hs</italic>MMADHC<sub>Î123-D226A</sub> (<italic>lane 6</italic>), and <italic>Hs</italic>MMADHC<sub>Î123-L259P</sub> (<italic>lane 7</italic>). <italic>White asterisks</italic> indicate the MMACHC-MMADHC heterodimer.</p>
              </caption>
              <graphic xlink:href="zbc0521532450005"/>
            </fig>
          </sec>
          <sec>
            <title>A Structural Model of the MMACHC-MMADHC Complex</title>
            <p>We next utilized SAXS, a low-resolution structural characterization method in solution (<xref rid="B34" ref-type="bibr">34</xref>), to construct a model of the MMACHC-MMADHC interaction. To ensure that the SAXS data most closely resembled the ordered aa regions revealed from the MMACHC and MMADHC structures, we reconstituted a complex from untagged <italic>Mm</italic>MMADHC<sub>Î128</sub> and untagged <italic>Hs</italic>MMACHC<sub>ÎC</sub> proteins in the presence of MeCbl and GSH. The Guinier approximation and pair distribution function P(r) calculated from the scattering data (<xref ref-type="fig" rid="F6">Fig. 6</xref>, <italic>A</italic> and <italic>B</italic>) suggest a radius of gyration (<italic>R<sub>g</sub></italic>) of 24.7 â« and maximal intraparticle dimension (<italic>D</italic><sub>max</sub>) of 80 â« for the complex, both parameters larger than those from either protein component alone (<xref ref-type="fig" rid="F6">Fig. 6</xref><italic>C</italic>). Further, the elution time of the protein complex from the in-line HPLC column was earlier than either protein alone, giving rise to a calculated molecular weight consistent with a 1:1 stoichiometry (<xref ref-type="fig" rid="F6">Fig. 6</xref><italic>C</italic>). The <italic>ab initio</italic> envelope of the <italic>Mm</italic>MMADHC<sub>Î128</sub>-alone sample fits well to one monomer (<xref ref-type="fig" rid="F6">Fig. 6</xref><italic>D</italic>). MMACHC is known to exist in a monomer:dimer equilibrium (<xref ref-type="fig" rid="F1">Fig. 1</xref>) (<xref rid="B16" ref-type="bibr">16</xref>), and the monomeric species selected for SAXS analysis is consistent with one protomer in the <italic>ab initio</italic> envelope (<xref ref-type="fig" rid="F6">Fig. 6</xref><italic>E</italic>). However, for the MMACHC-MMADHC complex, the <italic>ab initio</italic> envelope (<xref ref-type="fig" rid="F6">Fig. 6</xref><italic>F</italic>) gives an elongated dimension of 80, 40, and 40 â«. One protomer from each of <italic>Hs</italic>MMACHC<sub>ÎC</sub> and <italic>Mm</italic>MMADHC<sub>Î128</sub> would account for all the mass of the envelope, further indicating a 1:1 heterodimeric stoichiometry that agrees with our BN-PAGE, size-exclusion chromatography, and native mass spectrometry data (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Although the relative orientation of both proteins cannot be ascertained by SAXS, we applied our mutagenesis and interaction data (<xref ref-type="fig" rid="F5">Fig. 5</xref>) to direct protein docking of the complex using the ZDOCK server (<xref rid="B35" ref-type="bibr">35</xref>), given that residue Thr-182 of <italic>Mm</italic>MMADHC should be involved in the interaction. With this constraint, the top seven models generated from ZDOCK (<xref ref-type="fig" rid="F6">Fig. 6</xref><italic>F</italic>) all yield a good fit (Ï<sup>2</sup> â¼0.03â0.04) to the measured scattering. These models are consistent with an MMACHC-MMADHC interface that involves the Cbl binding region of MMACHC and aa 182â189 (<xref ref-type="fig" rid="F5">Fig. 5</xref>, <italic>stretch 1</italic>) of MMADHC (<xref ref-type="fig" rid="F6">Fig. 6</xref><italic>G</italic>). A similar docking run was performed with HADDOCK (<xref rid="B36" ref-type="bibr">36</xref>), yielding consistent models (data not shown).</p>
            <fig id="F6" orientation="portrait" position="float">
              <label>FIGURE 6.</label>
              <caption>
                <p><bold>SAXS analysis of the MMACHC-MMADHC interaction.</bold>
<italic>A</italic>, raw scattering curves for <italic>Mm</italic>MMADHC<sub>Î128</sub> (<italic>red</italic>), <italic>Hs</italic>MMACHC<sub>ÎC</sub> (<italic>blue</italic>), and their complex (<italic>black</italic>). <italic>B</italic>, P(r) plots, calculated with Scatter (<xref rid="B27" ref-type="bibr">27</xref>) and normalized to peak height, show differences between the single proteins and the complex. Guinier plots indicate aggregation-free data. <italic>C</italic>, table of radius of gyration (<italic>R<sub>g</sub></italic>), maximal intraparticle dimension (<italic>D</italic><sub>max</sub>) as calculated from the Guinier plot, apparent molecular weight (<italic>MW</italic>), and elution time from the in-line HPLC column. <italic>D</italic> and <italic>E</italic>, <italic>ab initio</italic> bead models calculated with 13 runs of DAMMIF (<xref rid="B39" ref-type="bibr">39</xref>) for <italic>Mm</italic>MMADHC<sub>Î128</sub> fitted with its x-ray structure (this study) (<italic>D</italic>) and <italic>Hs</italic>MMACHC<sub>ÎC</sub> fitted with its x-ray structure (PDB: <ext-link ext-link-type="pdb" xlink:href="3SOM">3SOM</ext-link>) (<italic>E</italic>). <italic>F</italic>, top seven models of the <italic>Hs</italic>MMACHC<sub>ÎC</sub>-<italic>Mm</italic>MMADHC<sub>Î128</sub> complex produced by ZDOCK with fitted Ï<sup>2</sup> values shown. The SAXS envelope is overlaid with modeled orientations of <italic>Hs</italic>MMACHC<sub>ÎC</sub> (<italic>blue</italic>) and <italic>Mm</italic>MMADHC<sub>Î128</sub> (<italic>red</italic>) structures. <italic>Mm</italic>MMADHC<sub>Î128</sub> is presented in the same orientation on all models for better comparison. <italic>G</italic>, <italic>Hs</italic>MMACHC<sub>ÎC</sub>-<italic>Mm</italic>MMADHC<sub>Î128</sub> complex fitted with a representative example of the ZDOCK (<xref rid="B35" ref-type="bibr">35</xref>) complex model. In <italic>E</italic> and <italic>G</italic>, Cbl is shown as <italic>purple sticks</italic>.</p>
              </caption>
              <graphic xlink:href="zbc0521532450006"/>
            </fig>
          </sec>
        </sec>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The role of MMACHC within the early stages of the Cbl processing pathway has previously been clarified from the available structural and biochemical evidence of its Cbl binding and processing activities (<xref rid="B16" ref-type="bibr">16</xref><xref ref-type="bibr" rid="B17">â</xref><xref rid="B20" ref-type="bibr">20</xref>). By contrast, the role of MMADHC, tasked with directing Cbl to the destination enzymes yet unable to bind Cbl itself, is much less clear. This study presents the first structural characterization of MMADHC to provide novel insights into its unknown function, with the key findings that: (i) MMADHC functions by binding Cbl-laden MMACHC, but only post-Cbl processing, <italic>i.e.</italic> after the upper axial ligand of Cbl has been removed; (ii) the MMACHC interaction module of MMADHC contains an ingeniously modified NTR fold that abolishes homodimerization, favors heterodimerization with another modified NTR fold from MMACHC, and accounts for the reported lack of Cbl binding (<xref rid="B13" ref-type="bibr">13</xref>); and (iii) missense mutations of MMADHC that reduced both AdoCbl and MeCbl production in cells can be explained at least in part by an abrogated interaction with MMACHC.</p>
      <p>Our data illustrate the application of protein-protein interaction in the early Cbl-targeting steps of the pathway for both the mitochondrial (AdoCbl to MUT) and the cytosolic (MeCbl to MS) targeting routes. Such protein-protein interaction is essential to the targeting process, and is disrupted by a known disease mutation of MMACHC that precludes B<sub>12</sub> processing and by mutations of MMADHC that alter the binding interface. We propose a mechanistic model for the MMACHC-MMADHC complex whereby the adaptation of the NTR fold by both proteins favors heterodimerization to form the âCbl trafficking chaperone.â In this model, MMACHC in the Cbl-free form could exist in a monomer-homodimer equilibrium (<xref ref-type="fig" rid="F7">Fig. 7</xref><italic>A</italic>). The self-association of MMACHC into homodimer, likely with a high dissociation rate that precludes its isolation <italic>in vitro</italic> (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>), is enriched in the presence of Cbl ligand (<xref ref-type="fig" rid="F7">Fig. 7</xref><italic>B</italic>) and may serve to close the enzymatic active site for proper Cbl processing (<xref rid="B16" ref-type="bibr">16</xref>) (<xref ref-type="fig" rid="F7">Fig. 7</xref><italic>C</italic>). Cbl-laden MMACHC (monomer/homodimer), with the upper axial ligand now removed, preferentially binds monomeric MMADHC as a 1:1 heterodimer rather than binding to itself, resulting in the âtrafficking chaperoneâ that delivers processed Cbl to its target destinations (<xref ref-type="fig" rid="F7">Fig. 7</xref><italic>D</italic>).</p>
      <fig id="F7" orientation="portrait" position="float">
        <label>FIGURE 7.</label>
        <caption>
          <p><bold>Proposed role of the MMACHC-MMADHC complex in Cbl targeting.</bold>
<italic>A</italic>, MMACHC (<italic>blue sector</italic>) in the unbound state exists primarily as a monomer. <italic>B</italic>, upon binding unprocessed Cbl with an intact upper axial ligand (<italic>triangle</italic>), it can shift toward the homodimeric state. <italic>C</italic>, following processing of Cbl (<italic>green</italic> to <italic>red triangle</italic>) via GSH-mediated removal of its upper axial ligand (<italic>green stick</italic> and <italic>square</italic>), MMACHC is available for interaction with MMADHC (<italic>orange sector</italic>). <italic>D</italic>, MMADHC binds MMACHC in a 1:1 heterodimer and escorts Cbl-laden MMACHC either toward the mitochondria (<italic>star</italic>) for use by methylmalonyl-CoA MUT or to MS in the cytosol.</p>
        </caption>
        <graphic xlink:href="zbc0521532450007"/>
      </fig>
      <p>Interestingly, only the C-terminal 154 aa of MMADHC is required for the interaction with MMACHC. As such, the exact function of the MMADHC N terminus remains to be determined. Predicted to be largely disordered, the N-terminal â¼115 aa harbors a mitochondrial targeting sequence (aa 1â12) and has been shown to be required for cellular AdoCbl production only (<xref rid="B11" ref-type="bibr">11</xref>). Thus, this protein region is likely only required for function within, or direction to, the mitochondria.</p>
      <p>Because MMADHC mutations that abolished direct interaction with MMACHC result in the combined HC+MMA phenotype (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>), it is conceivable that disruption of the MMACHC-MMADHC complex will result in an inability to deliver Cbl to both destination enzymes MS and MUT. A possible role of MMACHC in the mitochondria, where it has not been detected either on its own or in complex (<xref rid="B37" ref-type="bibr">37</xref>), remains undetermined. The dysfunction caused by <italic>MMADHC</italic> missense mutations, which result in a loss of MS activity only, <italic>i.e.</italic> the so-called <italic>cblD</italic>-HC mutations (<xref rid="B10" ref-type="bibr">10</xref>), also remains unexplained. Because MMACHC has recently been shown to bind various isoforms of MS (<xref rid="B38" ref-type="bibr">38</xref>), the <italic>cblD</italic>-HC mutations could affect a larger, yet unidentified multi-protein complex, likely including at least MMACHC and MS, but possibly also methionine synthase reductase.</p>
      <p>In conclusion, we have structurally characterized the MMACHC-interacting module of MMADHC and demonstrated that specific MMADHC mutations that cause combined loss of AdoCbl and MeCbl production in cells can interfere with MMACHC interaction. Further studies will clarify the affinity of these proteins for each other, and how this protein-protein interaction results in Cbl delivery in the cellular context.</p>
    </sec>
    <sec>
      <title>Author Contributions</title>
      <p>B. F., D. S. F., M. R. B., and W. W. Y. conceived of the study. D. S. F., T. P., and V. F. cloned the MMADHC constructs. D. S. F., J. K., and F. F. purified, crystallized and determined structure of MMADHC. F. F. and J. K. reconstituted the complex and carried out SAXS analysis. M. S. and T. J. M. performed BN-PAGE. M. S. and R. C. performed and analyzed native mass spectrometry. D. S. F. and W. W. Y. wrote the manuscript with editing and proofreading support from all other co-authors.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by" id="FN1">
        <label>*</label>
        <p>This work was supported by the Swiss National Science Foundation (Grants SNSF 31003A_156907 and SNSF 31003A_138521) (to D. S. F., M. R. B., B. F. and T. P.). This work was also supported by the Rare Disease Initiative Zurich, Clinical Research Priority Program, University of Zurich (to D. S. F. and M. R. B.). The Structural Genomics Consortium is a registered charity (Number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, Glaxo-SmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z). The authors declare that they have no conflicts of interest with the contents of this article.</p>
      </fn>
      <fn fn-type="other">
        <p>The atomic coordinates and structure factors (code <ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/pdb/explore/explore.do?structureId=5A4R">5A4R</ext-link>) have been deposited in the Protein Data Bank (<ext-link ext-link-type="uri" xlink:href="http://www.pdb.org/">http://wwpdb.org/</ext-link>).</p>
      </fn>
    </fn-group>
    <fn-group content-type="abbreviations">
      <fn id="FN4">
        <label>5</label>
        <p>The abbreviations used are:
<def-list><def-item><term id="G1">Cbl</term><def><p>cobalamin</p></def></def-item><def-item><term id="G2">MeCbl</term><def><p>methyl-Cbl</p></def></def-item><def-item><term id="G3">AdoCbl</term><def><p>adenosyl-Cbl</p></def></def-item><def-item><term id="G4">CNCbl</term><def><p>cyanocobalamin</p></def></def-item><def-item><term id="G5">MS</term><def><p>methionine synthase</p></def></def-item><def-item><term id="G6">MUT</term><def><p>methylmalonyl-CoA mutase</p></def></def-item><def-item><term id="G7">HC</term><def><p>homocystinuria</p></def></def-item><def-item><term id="G8">MMA</term><def><p>methylmalonic aciduria</p></def></def-item><def-item><term id="G9">aa</term><def><p>amino acid(s)</p></def></def-item><def-item><term id="G10">SAXS</term><def><p>small-angle x-ray scattering</p></def></def-item><def-item><term id="G11">NTR</term><def><p>nitroreductase</p></def></def-item><def-item><term id="G12">SeMet</term><def><p>selenomethionine</p></def></def-item><def-item><term id="G13">BN-PAGE</term><def><p>blue native-PAGE</p></def></def-item><def-item><term id="G14">Bis-Tris</term><def><p>2-(bis(2-hydroxyethyl)amino)-2-(hydroxymethyl)propane-1,3-diol</p></def></def-item><def-item><term id="G15">r.m.s.d</term><def><p>root mean square deviation</p></def></def-item><def-item><term id="G16">FL</term><def><p>full-length</p></def></def-item><def-item><term id="G17"><italic>Hs</italic></term><def><p><italic>Homo sapiens</italic></p></def></def-item><def-item><term id="G18"><italic>Mm</italic></term><def><p><italic>Mus musculus</italic>.</p></def></def-item></def-list></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank the Diamond Light Source for access to the beamlines I04 and B21 (MX10619), and James Doutch for help with SAXS data collection and processing.</p>
    </ack>
    <notes>
      <title>Addendum</title>
      <p>During the revision of this manuscript, Yamada <italic>et al.</italic> (<italic>J. Biol. Chem.</italic>, 10.1074/jbc.M115.682435 (<xref rid="B40" ref-type="bibr">40</xref>)) reported the human MMADHC structure of a region corresponding to our mouse structure, and consistent with our structural observations described here.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>D.</given-names></name>, and <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name></person-group> (<year>2014</year>) <article-title>Inherited disorders of folate and cobalamin transport and metabolism</article-title>. in <source>The Online Metabolic and Molecular Bases of Inherited Disease</source> (<person-group person-group-type="editor"><name><surname>Valle</surname><given-names>D.</given-names></name>, <name><surname>Beaudet</surname><given-names>A. L.</given-names></name>, <name><surname>Vogelstein</surname><given-names>B.</given-names></name>, <name><surname>Kinzler</surname><given-names>K. W.</given-names></name>, <name><surname>Antonarakis</surname><given-names>S. E.</given-names></name>, <name><surname>Ballabio</surname><given-names>A.</given-names></name>, <name><surname>Gibson</surname><given-names>M.</given-names></name>, and <name><surname>Mitchell</surname><given-names>G.</given-names></name></person-group>, eds), <publisher-name>McGraw-Hill</publisher-name>, <publisher-loc>New York</publisher-loc></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froese</surname><given-names>D. S.</given-names></name>, and <name><surname>Gravel</surname><given-names>R. A.</given-names></name></person-group> (<year>2010</year>) <article-title>Genetic disorders of vitamin B metabolism: eight complementation groupsâeight genes</article-title>. <source>Expert Rev. Mol. Med</source>. <volume>12</volume>, <fpage>e37</fpage><pub-id pub-id-type="pmid">21114891</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gherasim</surname><given-names>C.</given-names></name>, <name><surname>Lofgren</surname><given-names>M.</given-names></name>, and <name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>) <article-title>Navigating the B<sub>12</sub> road: assimilation, delivery, and disorders of cobalamin</article-title>. <source>J. Biol. Chem</source>. <volume>288</volume>, <fpage>13186</fpage>â<lpage>13193</lpage><pub-id pub-id-type="pmid">23539619</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgartner</surname><given-names>M. R.</given-names></name></person-group> (<year>2013</year>) <article-title>Vitamin-responsive disorders: cobalamin, folate, biotin, vitamins B<sub>1</sub> and E</article-title>. <source>Handb. Clin. Neurol</source>. <volume>113</volume>, <fpage>1799</fpage>â<lpage>1810</lpage><pub-id pub-id-type="pmid">23622402</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>C. O.</given-names></name>, <name><surname>Arnold</surname><given-names>G.</given-names></name>, <name><surname>Barness</surname><given-names>L. A.</given-names></name>, <name><surname>Wolff</surname><given-names>J. A.</given-names></name>, and <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name></person-group> (<year>1997</year>) <article-title>Functional methionine synthase deficiency due to cblG disorder: a report of two patients and a review</article-title>. <source>Am. J. Med. Genet</source>. <volume>71</volume>, <fpage>384</fpage>â<lpage>390</lpage><pub-id pub-id-type="pmid">9286442</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HÃ¶rster</surname><given-names>F.</given-names></name>, <name><surname>Baumgartner</surname><given-names>M. R.</given-names></name>, <name><surname>Viardot</surname><given-names>C.</given-names></name>, <name><surname>Suormala</surname><given-names>T.</given-names></name>, <name><surname>Burgard</surname><given-names>P.</given-names></name>, <name><surname>Fowler</surname><given-names>B.</given-names></name>, <name><surname>Hoffmann</surname><given-names>G. F.</given-names></name>, <name><surname>Garbade</surname><given-names>S. F.</given-names></name>, <name><surname>KÃ¶lker</surname><given-names>S.</given-names></name>, and <name><surname>Baumgartner</surname><given-names>E. R.</given-names></name></person-group> (<year>2007</year>) <article-title>Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut<sup>0</sup>, mut<sup>â</sup>, cblA, cblB)</article-title>. <source>Pediatr. Res</source>. <volume>62</volume>, <fpage>225</fpage>â<lpage>230</lpage><pub-id pub-id-type="pmid">17597648</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>B.</given-names></name>, <name><surname>Leonard</surname><given-names>J. V.</given-names></name>, and <name><surname>Baumgartner</surname><given-names>M. R.</given-names></name></person-group> (<year>2008</year>) <article-title>Causes of and diagnostic approach to methylmalonic acidurias</article-title>. <source>J. Inherit. Metab. Dis</source>. <volume>31</volume>, <fpage>350</fpage>â<lpage>360</lpage><pub-id pub-id-type="pmid">18563633</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner-Ellis</surname><given-names>J. P.</given-names></name>, <name><surname>Anastasio</surname><given-names>N.</given-names></name>, <name><surname>Liu</surname><given-names>J.</given-names></name>, <name><surname>Coelho</surname><given-names>D.</given-names></name>, <name><surname>Suormala</surname><given-names>T.</given-names></name>, <name><surname>Stucki</surname><given-names>M.</given-names></name>, <name><surname>Loewy</surname><given-names>A. D.</given-names></name>, <name><surname>Gurd</surname><given-names>S.</given-names></name>, <name><surname>Grundberg</surname><given-names>E.</given-names></name>, <name><surname>Morel</surname><given-names>C. F.</given-names></name>, <name><surname>Watkins</surname><given-names>D.</given-names></name>, <name><surname>Baumgartner</surname><given-names>M. R.</given-names></name>, <name><surname>Pastinen</surname><given-names>T.</given-names></name>, <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name>, and <name><surname>Fowler</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>) <article-title>Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations</article-title>. <source>Hum. Mutat</source>. <volume>30</volume>, <fpage>1072</fpage>â<lpage>1081</lpage><pub-id pub-id-type="pmid">19370762</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suormala</surname><given-names>T.</given-names></name>, <name><surname>Baumgartner</surname><given-names>M. R.</given-names></name>, <name><surname>Coelho</surname><given-names>D.</given-names></name>, <name><surname>Zavadakova</surname><given-names>P.</given-names></name>, <name><surname>Kozich</surname><given-names>V.</given-names></name>, <name><surname>Koch</surname><given-names>H. G.</given-names></name>, <name><surname>BerghaÃ¼ser</surname><given-names>M.</given-names></name>, <name><surname>Wraith</surname><given-names>J. E.</given-names></name>, <name><surname>Burlina</surname><given-names>A.</given-names></name>, <name><surname>Sewell</surname><given-names>A.</given-names></name>, <name><surname>Herwig</surname><given-names>J.</given-names></name>, and <name><surname>Fowler</surname><given-names>B.</given-names></name></person-group> (<year>2004</year>) <article-title>The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis</article-title>. <source>J. Biol. Chem</source>. <volume>279</volume>, <fpage>42742</fpage>â<lpage>42749</lpage><pub-id pub-id-type="pmid">15292234</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>D.</given-names></name>, <name><surname>Suormala</surname><given-names>T.</given-names></name>, <name><surname>Stucki</surname><given-names>M.</given-names></name>, <name><surname>Lerner-Ellis</surname><given-names>J. P.</given-names></name>, <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name>, <name><surname>Newbold</surname><given-names>R. F.</given-names></name>, <name><surname>Baumgartner</surname><given-names>M. R.</given-names></name>, and <name><surname>Fowler</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>) <article-title>Gene identification for the cblD defect of vitamin B<sub>12</sub> metabolism</article-title>. <source>N. Engl. J. Med</source>. <volume>358</volume>, <fpage>1454</fpage>â<lpage>1464</lpage><pub-id pub-id-type="pmid">18385497</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stucki</surname><given-names>M.</given-names></name>, <name><surname>Coelho</surname><given-names>D.</given-names></name>, <name><surname>Suormala</surname><given-names>T.</given-names></name>, <name><surname>Burda</surname><given-names>P.</given-names></name>, <name><surname>Fowler</surname><given-names>B.</given-names></name>, and <name><surname>Baumgartner</surname><given-names>M. R.</given-names></name></person-group> (<year>2012</year>) <article-title>Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism</article-title>. <source>Hum. Mol. Genet</source>. <volume>21</volume>, <fpage>1410</fpage>â<lpage>1418</lpage><pub-id pub-id-type="pmid">22156578</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jusufi</surname><given-names>J.</given-names></name>, <name><surname>Suormala</surname><given-names>T.</given-names></name>, <name><surname>Burda</surname><given-names>P.</given-names></name>, <name><surname>Fowler</surname><given-names>B.</given-names></name>, <name><surname>Froese</surname><given-names>D. S.</given-names></name>, and <name><surname>Baumgartner</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>) <article-title>Characterization of functional domains of the <italic>cblD</italic> (MMADHC) gene product</article-title>. <source>J. Inherit. Metab. Dis</source>. <volume>37</volume>, <fpage>841</fpage>â<lpage>849</lpage><pub-id pub-id-type="pmid">24722857</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deme</surname><given-names>J. C.</given-names></name>, <name><surname>Miousse</surname><given-names>I. R.</given-names></name>, <name><surname>Plesa</surname><given-names>M.</given-names></name>, <name><surname>Kim</surname><given-names>J. C.</given-names></name>, <name><surname>Hancock</surname><given-names>M. A.</given-names></name>, <name><surname>Mah</surname><given-names>W.</given-names></name>, <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name>, and <name><surname>Coulton</surname><given-names>J. W.</given-names></name></person-group> (<year>2012</year>) <article-title>Structural features of recombinant MMADHC isoforms and their interactions with MMACHC, proteins of mammalian vitamin B<sub>12</sub> metabolism</article-title>. <source>Mol. Genet. Metab</source>. <volume>107</volume>, <fpage>352</fpage>â<lpage>362</lpage><pub-id pub-id-type="pmid">22832074</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gherasim</surname><given-names>C.</given-names></name>, <name><surname>Hannibal</surname><given-names>L.</given-names></name>, <name><surname>Rajagopalan</surname><given-names>D.</given-names></name>, <name><surname>Jacobsen</surname><given-names>D. W.</given-names></name>, and <name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>) <article-title>The C-terminal domain of CblD interacts with CblC and influences intracellular cobalamin partitioning</article-title>. <source>Biochimie</source>
<volume>95</volume>, <fpage>1023</fpage>â<lpage>1032</lpage><pub-id pub-id-type="pmid">23415655</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plesa</surname><given-names>M.</given-names></name>, <name><surname>Kim</surname><given-names>J.</given-names></name>, <name><surname>Paquette</surname><given-names>S. G.</given-names></name>, <name><surname>Gagnon</surname><given-names>H.</given-names></name>, <name><surname>Ng-Thow-Hing</surname><given-names>C.</given-names></name>, <name><surname>Gibbs</surname><given-names>B. F.</given-names></name>, <name><surname>Hancock</surname><given-names>M. A.</given-names></name>, <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name>, and <name><surname>Coulton</surname><given-names>J. W.</given-names></name></person-group> (<year>2011</year>) <article-title>Interaction between MMACHC and MMADHC, two human proteins participating in intracellular vitamin B<sub>12</sub> metabolism</article-title>. <source>Mol. Genet. Metab</source>. <volume>102</volume>, <fpage>139</fpage>â<lpage>148</lpage><pub-id pub-id-type="pmid">21071249</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froese</surname><given-names>D. S.</given-names></name>, <name><surname>Krojer</surname><given-names>T.</given-names></name>, <name><surname>Wu</surname><given-names>X.</given-names></name>, <name><surname>Shrestha</surname><given-names>R.</given-names></name>, <name><surname>Kiyani</surname><given-names>W.</given-names></name>, <name><surname>von Delft</surname><given-names>F.</given-names></name>, <name><surname>Gravel</surname><given-names>R. A.</given-names></name>, <name><surname>Oppermann</surname><given-names>U.</given-names></name>, and <name><surname>Yue</surname><given-names>W. W.</given-names></name></person-group> (<year>2012</year>) <article-title>Structure of MMACHC reveals an arginine-rich pocket and a domain-swapped dimer for its B<sub>12</sub> processing function</article-title>. <source>Biochemistry</source>
<volume>51</volume>, <fpage>5083</fpage>â<lpage>5090</lpage><pub-id pub-id-type="pmid">22642810</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koutmos</surname><given-names>M.</given-names></name>, <name><surname>Gherasim</surname><given-names>C.</given-names></name>, <name><surname>Smith</surname><given-names>J. L.</given-names></name>, and <name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2011</year>) <article-title>Structural basis of multifunctionality in a vitamin B<sub>12</sub>-processing enzyme</article-title>. <source>J. Biol. Chem</source>. <volume>286</volume>, <fpage>29780</fpage>â<lpage>29787</lpage><pub-id pub-id-type="pmid">21697092</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froese</surname><given-names>D. S.</given-names></name>, <name><surname>Zhang</surname><given-names>J.</given-names></name>, <name><surname>Healy</surname><given-names>S.</given-names></name>, and <name><surname>Gravel</surname><given-names>R. A.</given-names></name></person-group> (<year>2009</year>) <article-title>Mechanism of vitamin B<sub>12</sub>-responsiveness in <italic>cblC</italic> methylmalonic aciduria with homocystinuria</article-title>. <source>Mol. Genet. Metab</source>. <volume>98</volume>, <fpage>338</fpage>â<lpage>343</lpage><pub-id pub-id-type="pmid">19700356</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name>, <name><surname>Gherasim</surname><given-names>C.</given-names></name>, and <name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>) <article-title>Decyanation of vitamin B<sub>12</sub> by a trafficking chaperone</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>105</volume>, <fpage>14551</fpage>â<lpage>14554</lpage><pub-id pub-id-type="pmid">18779575</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannibal</surname><given-names>L.</given-names></name>, <name><surname>Kim</surname><given-names>J.</given-names></name>, <name><surname>Brasch</surname><given-names>N. E.</given-names></name>, <name><surname>Wang</surname><given-names>S.</given-names></name>, <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name>, <name><surname>Banerjee</surname><given-names>R.</given-names></name>, and <name><surname>Jacobsen</surname><given-names>D. W.</given-names></name></person-group> (<year>2009</year>) <article-title>Processing of alkylcobalamins in mammalian cells: A role for the <italic>MMACHC</italic> (<italic>cblC</italic>) gene product</article-title>. <source>Mol. Genet. Metab</source>. <volume>97</volume>, <fpage>260</fpage>â<lpage>266</lpage><pub-id pub-id-type="pmid">19447654</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froese</surname><given-names>D. S.</given-names></name>, <name><surname>Healy</surname><given-names>S.</given-names></name>, <name><surname>McDonald</surname><given-names>M.</given-names></name>, <name><surname>Kochan</surname><given-names>G.</given-names></name>, <name><surname>Oppermann</surname><given-names>U.</given-names></name>, <name><surname>Niesen</surname><given-names>F. H.</given-names></name>, and <name><surname>Gravel</surname><given-names>R. A.</given-names></name></person-group> (<year>2010</year>) <article-title>Thermolability of mutant MMACHC protein in the vitamin B<sub>12</sub>-responsive <italic>cblC</italic> disorder</article-title>. <source>Mol. Genet. Metab</source>. <volume>100</volume>, <fpage>29</fpage>â<lpage>36</lpage><pub-id pub-id-type="pmid">20219402</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheldrick</surname><given-names>G. M.</given-names></name></person-group> (<year>2010</year>) <article-title>Experimental phasing with SHELXC/D/E: combining chain tracing with density modification</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr</source>. <volume>66</volume>, <fpage>479</fpage>â<lpage>485</lpage><pub-id pub-id-type="pmid">20383001</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowtan</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>) <article-title>The Buccaneer software for automated model building. 1. Tracing protein chains</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr</source>. <volume>62</volume>, <fpage>1002</fpage>â<lpage>1011</lpage><pub-id pub-id-type="pmid">16929101</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>, <name><surname>Adams</surname><given-names>P. D.</given-names></name>, <name><surname>Read</surname><given-names>R. J.</given-names></name>, <name><surname>McCoy</surname><given-names>A. J.</given-names></name>, <name><surname>Moriarty</surname><given-names>N. W.</given-names></name>, <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>, <name><surname>Afonine</surname><given-names>P. V.</given-names></name>, <name><surname>Zwart</surname><given-names>P. H.</given-names></name>, and <name><surname>Hung</surname><given-names>L. W.</given-names></name></person-group> (<year>2009</year>) <article-title>Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr</source>. <volume>65</volume>, <fpage>582</fpage>â<lpage>601</lpage><pub-id pub-id-type="pmid">19465773</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P.</given-names></name>, <name><surname>Lohkamp</surname><given-names>B.</given-names></name>, <name><surname>Scott</surname><given-names>W. G.</given-names></name>, and <name><surname>Cowtan</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>) <article-title>Features and development of Coot</article-title>. <source>Acta Crystallogr. D Biol. Crystallogr</source>. <volume>66</volume>, <fpage>486</fpage>â<lpage>501</lpage><pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>A. J.</given-names></name>, <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>, <name><surname>Adams</surname><given-names>P. D.</given-names></name>, <name><surname>Winn</surname><given-names>M. D.</given-names></name>, <name><surname>Storoni</surname><given-names>L. C.</given-names></name>, and <name><surname>Read</surname><given-names>R. J.</given-names></name></person-group> (<year>2007</year>) <article-title>Phaser crystallographic software</article-title>. <source>J. Appl. Crystallogr</source>. <volume>40</volume>, <fpage>658</fpage>â<lpage>674</lpage><pub-id pub-id-type="pmid">19461840</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foerster</surname><given-names>S.</given-names></name>, <name><surname>Apostol</surname><given-names>L.</given-names></name>, and <name><surname>Bras</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>) <article-title>Scatter: software for the analysis of nano- and mesoscale small-angle scattering</article-title>. <source>J. Appl. Crystallogr</source>. <volume>43</volume>, <fpage>639</fpage>â<lpage>646</lpage></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petoukhov</surname><given-names>M. V.</given-names></name>, <name><surname>Franke</surname><given-names>D.</given-names></name>, <name><surname>Shkumatov</surname><given-names>A. V.</given-names></name>, <name><surname>Tria</surname><given-names>G.</given-names></name>, <name><surname>Kikhney</surname><given-names>A. G.</given-names></name>, <name><surname>Gajda</surname><given-names>M.</given-names></name>, <name><surname>Gorba</surname><given-names>C.</given-names></name>, <name><surname>Mertens</surname><given-names>H. D.</given-names></name>, <name><surname>Konarev</surname><given-names>P. V.</given-names></name>, and <name><surname>Svergun</surname><given-names>D. I.</given-names></name></person-group> (<year>2012</year>) <article-title>New developments in the program package for small-angle scattering data analysis</article-title>. <source>J. Appl. Crystallogr</source>. <volume>45</volume>, <fpage>342</fpage>â<lpage>350</lpage><pub-id pub-id-type="pmid">25484842</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niesen</surname><given-names>F. H.</given-names></name>, <name><surname>Berglund</surname><given-names>H.</given-names></name>, and <name><surname>Vedadi</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>) <article-title>The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability</article-title>. <source>Nat. Protoc</source>. <volume>2</volume>, <fpage>2212</fpage>â<lpage>2221</lpage><pub-id pub-id-type="pmid">17853878</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name>, <name><surname>Hannibal</surname><given-names>L.</given-names></name>, <name><surname>Gherasim</surname><given-names>C.</given-names></name>, <name><surname>Jacobsen</surname><given-names>D. W.</given-names></name>, and <name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>) <article-title>A human vitamin B<sub>12</sub> trafficking protein uses glutathione transferase activity for processing alkylcobalamins</article-title>. <source>J. Biol. Chem</source>. <volume>284</volume>, <fpage>33418</fpage>â<lpage>33424</lpage><pub-id pub-id-type="pmid">19801555</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name>, <name><surname>Gherasim</surname><given-names>C.</given-names></name>, <name><surname>Lesniak</surname><given-names>N. A.</given-names></name>, and <name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>) <article-title>Glutathione-dependent one-electron transfer reactions catalyzed by a B<sub>12</sub> trafficking protein</article-title>. <source>J. Biol. Chem</source>. <volume>289</volume>, <fpage>16487</fpage>â<lpage>16497</lpage><pub-id pub-id-type="pmid">24742678</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gherasim</surname><given-names>C.</given-names></name>, <name><surname>Ruetz</surname><given-names>M.</given-names></name>, <name><surname>Li</surname><given-names>Z.</given-names></name>, <name><surname>Hudolin</surname><given-names>S.</given-names></name>, and <name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>) <article-title>Pathogenic mutations differentially affect the catalytic activities of the human B<sub>12</sub>-processing chaperone CblC and increase futile redox cycling</article-title>. <source>J. Biol. Chem</source>. <volume>290</volume>, <fpage>11393</fpage>â<lpage>11402</lpage><pub-id pub-id-type="pmid">25809485</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McWilliam</surname><given-names>H.</given-names></name>, <name><surname>Li</surname><given-names>W.</given-names></name>, <name><surname>Uludag</surname><given-names>M.</given-names></name>, <name><surname>Squizzato</surname><given-names>S.</given-names></name>, <name><surname>Park</surname><given-names>Y. M.</given-names></name>, <name><surname>Buso</surname><given-names>N.</given-names></name>, <name><surname>Cowley</surname><given-names>A. P.</given-names></name>, and <name><surname>Lopez</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>) <article-title>Analysis Tool Web Services from the EMBL-EBI</article-title>. <source>Nucleic Acids Res</source>. <volume>41</volume>, <fpage>W597</fpage>â<lpage>W600</lpage><pub-id pub-id-type="pmid">23671338</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mertens</surname><given-names>H. D.</given-names></name>, and <name><surname>Svergun</surname><given-names>D. I.</given-names></name></person-group> (<year>2010</year>) <article-title>Structural characterization of proteins and complexes using small-angle X-ray solution scattering</article-title>. <source>J. Struct. Biol</source>. <volume>172</volume>, <fpage>128</fpage>â<lpage>141</lpage><pub-id pub-id-type="pmid">20558299</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>B. G.</given-names></name>, <name><surname>Wiehe</surname><given-names>K.</given-names></name>, <name><surname>Hwang</surname><given-names>H.</given-names></name>, <name><surname>Kim</surname><given-names>B. H.</given-names></name>, <name><surname>Vreven</surname><given-names>T.</given-names></name>, and <name><surname>Weng</surname><given-names>Z.</given-names></name></person-group> (<year>2014</year>) <article-title>ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers</article-title>. <source>Bioinformatics</source>
<volume>30</volume>, <fpage>1771</fpage>â<lpage>1773</lpage><pub-id pub-id-type="pmid">24532726</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wassenaar</surname><given-names>T.</given-names></name>, <name><surname>van Dijk</surname><given-names>M.</given-names></name>, <name><surname>Loureiro-Ferreira</surname><given-names>N.</given-names></name>, <name><surname>van der Schot</surname><given-names>G.</given-names></name>, <name><surname>de Vries</surname><given-names>S.</given-names></name>, <name><surname>Schmitz</surname><given-names>C.</given-names></name>, <name><surname>van der Zwan</surname><given-names>J.</given-names></name>, <name><surname>Boelens</surname><given-names>R.</given-names></name>, <name><surname>Giachetti</surname><given-names>A.</given-names></name>, <name><surname>Ferella</surname><given-names>L.</given-names></name>, <name><surname>Rosato</surname><given-names>A.</given-names></name>, <name><surname>Bertini</surname><given-names>I.</given-names></name>, <name><surname>Herrmann</surname><given-names>T.</given-names></name>, <name><surname>Jonker</surname><given-names>H. A.</given-names></name>, <name><surname>Bagaria</surname><given-names>A.</given-names></name>, <name><surname>Jaravine</surname><given-names>V.</given-names></name>, <name><surname>GÃ¼ntert</surname><given-names>P.</given-names></name>, <name><surname>Schwalbe</surname><given-names>H.</given-names></name>, <name><surname>Vranken</surname><given-names>W.</given-names></name>, <name><surname>Doreleijers</surname><given-names>J.</given-names></name>, <name><surname>Vriend</surname><given-names>G.</given-names></name>, <name><surname>Vuister</surname><given-names>G.</given-names></name>, <name><surname>Franke</surname><given-names>D.</given-names></name>, <name><surname>Kikhney</surname><given-names>A.</given-names></name>, <name><surname>Svergun</surname><given-names>D.</given-names></name>, <name><surname>Fogh</surname><given-names>R.</given-names></name>, <name><surname>Ionides</surname><given-names>J.</given-names></name>, <name><surname>Laue</surname><given-names>E.</given-names></name>, <name><surname>Spronk</surname><given-names>C.</given-names></name>, <name><surname>JurkÅ¡a</surname><given-names>S.</given-names></name>, <name><surname>Verlato</surname><given-names>M.</given-names></name>, <name><surname>Badoer</surname><given-names>S.</given-names></name>, <name><surname>Dal Pra</surname><given-names>S.</given-names></name>, <name><surname>Mazzucato</surname><given-names>M.</given-names></name>, <name><surname>Frizziero</surname><given-names>E.</given-names></name>, and <name><surname>Bonvin</surname><given-names>A. J. J.</given-names></name></person-group> (<year>2012</year>) <article-title>WeNMR: structural biology on the grid</article-title>. <source>J. Grid Computing</source>
<volume>10</volume>, <fpage>743</fpage>â<lpage>767</lpage></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mah</surname><given-names>W.</given-names></name>, <name><surname>Deme</surname><given-names>J. C.</given-names></name>, <name><surname>Watkins</surname><given-names>D.</given-names></name>, <name><surname>Fung</surname><given-names>S.</given-names></name>, <name><surname>Janer</surname><given-names>A.</given-names></name>, <name><surname>Shoubridge</surname><given-names>E. A.</given-names></name>, <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name>, and <name><surname>Coulton</surname><given-names>J. W.</given-names></name></person-group> (<year>2013</year>) <article-title>Subcellular location of MMACHC and MMADHC, two human proteins central to intracellular vitamin B<sub>12</sub> metabolism</article-title>. <source>Mol. Genet. Metab</source>. <volume>108</volume>, <fpage>112</fpage>â<lpage>118</lpage><pub-id pub-id-type="pmid">23270877</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fofou-Caillierez</surname><given-names>M. B.</given-names></name>, <name><surname>Mrabet</surname><given-names>N. T.</given-names></name>, <name><surname>ChÃ©ry</surname><given-names>C.</given-names></name>, <name><surname>Dreumont</surname><given-names>N.</given-names></name>, <name><surname>Flayac</surname><given-names>J.</given-names></name>, <name><surname>Pupavac</surname><given-names>M.</given-names></name>, <name><surname>Paoli</surname><given-names>J.</given-names></name>, <name><surname>Alberto</surname><given-names>J. M.</given-names></name>, <name><surname>Coelho</surname><given-names>D.</given-names></name>, <name><surname>Camadro</surname><given-names>J. M.</given-names></name>, <name><surname>Feillet</surname><given-names>F.</given-names></name>, <name><surname>Watkins</surname><given-names>D.</given-names></name>, <name><surname>Fowler</surname><given-names>B.</given-names></name>, <name><surname>Rosenblatt</surname><given-names>D. S.</given-names></name>, and <name><surname>GuÃ©ant</surname><given-names>J. L.</given-names></name></person-group> (<year>2013</year>) <article-title>Interaction between methionine synthase isoforms and MMACHC: characterization in <italic>cblG</italic>-variant, <italic>cblG</italic> and <italic>cblC</italic> inherited causes of megaloblastic anaemia</article-title>. <source>Hum. Mol. Genet</source>. <volume>22</volume>, <fpage>4591</fpage>â<lpage>4601</lpage><pub-id pub-id-type="pmid">23825108</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franke</surname><given-names>D.</given-names></name>, and <name><surname>Svergun</surname><given-names>D. I.</given-names></name></person-group> (<year>2009</year>) <article-title>DAMMIF, a program for rapid <italic>ab-initio</italic> shape determination in small-angle scattering</article-title>. <source>J. Appl. Crystallogr</source>. <volume>42</volume>, <fpage>342</fpage>â<lpage>346</lpage></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>K.</given-names></name>, <name><surname>Gherasim</surname><given-names>C.</given-names></name>, <name><surname>Banerjee</surname><given-names>R.</given-names></name>, and <name><surname>Koutmos</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>) <article-title>Structure of human B<sub>12</sub> trafficking protein Cb1D reveals molecular mimicry and identifies a new subfamily of nitro-FMN reductases</article-title>. <source>J. Biol. Chem</source>. <volume>290</volume>, <fpage>29155</fpage>â<lpage>29166</lpage><pub-id pub-id-type="pmid">26364851</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>